Vanda Pharmaceuticals Inc (VNDA) — Free Cash Flow Generation Index

Latest as of March 2024: 1.00x

Vanda Pharmaceuticals Inc (VNDA) has a Free Cash Flow Generation Index of 1.00x as of March 2024. Free cash flow of $7.56 Million represents 1% of operating cash flow ($7.57 Million). Explore how much does Vanda Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$7.56 Million
USD

Operating Cash Flow

$7.57 Million
USD

Capital Expenditures

$7.00K
USD

Vanda Pharmaceuticals Inc Free Cash Flow Generation Index (2009–2023)

Historical FCF Generation Index trend for Vanda Pharmaceuticals Inc across 8 annual periods. For the full cash flow conversion analysis, see Vanda Pharmaceuticals Inc operating cash flow efficiency.

Annual Free Cash Flow Generation for Vanda Pharmaceuticals Inc (2009–2023)

Year-by-year Free Cash Flow Generation Index for Vanda Pharmaceuticals Inc. Check VNDA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 0.97x $12.42 Million $12.80 Million $383.00K ▼ -0.9%
2022 0.98x $31.30 Million $31.98 Million $679.00K ▼ -1.3%
2021 0.99x $63.66 Million $64.21 Million $552.00K ▲ +2.7%
2020 0.97x $49.98 Million $51.77 Million $1.79 Million ▼ -1.3%
2019 0.98x $44.93 Million $45.95 Million $1.02 Million ▲ +534.9%
2018 0.15x $4.62 Million $29.99 Million $25.37 Million ▼ -80.7%
2015 0.80x $9.92 Million $12.45 Million $2.53 Million ▼ -14.2%
2009 0.93x $157.34 Million $169.34 Million $12.00 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).